Stavaster Tablet 20 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium
Prescription medication
Korea Sandos Co., Ltd.
MFDS item code 201404476 · Approved 2014.09.30
This product's status changed to Approval withdrawn on 2023.06.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of dyslipidemia, reduction of cardiovascular disease risk, and inhibition of atherosclerosis progression
This medication is primarily used in patients with primary hypercholesterolemia and mixed dyslipidemia when diet and exercise alone are insufficient. It is particularly used as an adjunct to diet or other therapies in patients with familial hypercholesterolemia to lower total cholesterol and LDL cholesterol levels. This helps delay the progression of atherosclerosis. Additionally, it is used as an adjunct to diet in pediatric patients aged 10 to 17 who meet specific criteria. It is effective in reducing the risk of stroke, myocardial infarction, and vascular interventions in patients at high risk for cardiovascular diseases. This medication is used for major lipid abnormalities and the reduction of cardiovascular disease risk.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug, and should continue it throughout the treatment period. This drug may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient for most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased to a maximum of 20 milligrams daily. 3. Older adults: Dose adjustment is not necessary. 4. Patients with renal impairment: Dose adjustment is not necessary in patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering 20mg of this drug to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer this drug to patients with active liver disease. 6. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this drug is contraindicated in some of these patients.
Age 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.
This medication should not be used in specific patients. For example, it is contraindicated for patients with an allergy to any component of this medication, those with severe liver dysfunction, patients with muscle disorders, those taking certain immunosuppressants, patients with severely reduced kidney function, pregnant or breastfeeding women, and fertile women not using appropriate contraception. Additionally, high-dose use is prohibited in patients with a high risk of muscle disorders. This medication contains lactose, so it should not be used by patients with lactose intolerance or specific genetic metabolic disorders. Caution should be exercised in patients with liver dysfunction or excessive alcohol consumption, and it is important to regularly check liver function before and during treatment. Symptoms such as muscle pain, weakness, and damage may occur; if these symptoms appear, medical personnel should be informed immediately. Particularly, patients at high risk of muscle damage should have muscle enzyme levels checked before starting treatment, and routine monitoring through symptoms and tests is necessary during treatment. In cases of acute renal failure or severe systemic diseases, use of this medication should be discontinued. This medication may increase the risk of muscle damage when used in conjunction with other specific drugs, so if any medications are being taken concurrently, this must be disclosed to medical personnel. Using high doses of this medication may cause transient proteinuria, necessitating kidney function tests. For Asians, the drug may accumulate more in the body, so dose adjustment may be necessary. In pediatric patients aged 10 to 17, the impact on growth and secondary sexual characteristics is limited, requiring caution. During the use of this medication, rare side effects such as interstitial lung disease, severe liver damage, and severe skin reactions may occur; if symptoms appear, treatment should be discontinued immediately, and advice from medical personnel should be sought. Furthermore, this medication can raise blood sugar levels, so patients at high risk for diabetes require regular blood sugar checks. This medication can interact with many drugs, so if other medications are being taken, this should be disclosed to medical personnel, especially with particular antiviral agents, immunosuppressants, and fibrate class medications. It should be avoided during pregnancy or breastfeeding, and women who may become pregnant should use appropriate birth control methods. In case of overdose, there are no specific antidotes, and treatment should be symptomatic while monitoring liver function and muscle enzyme levels. Finally, this medication may cause dizziness, so precautions should be taken while driving or operating machinery.
Hypertensive reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal hepatic failure, cognitive impairment, increased ALT, chest pain, increased CK, increased AST, joint pain, fatigue, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, acute renal failure, oliguria, increased serum creatinine
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. Additionally, it is best to store it at room temperature between 1°C and 30°C, avoiding extremely hot or cold places.
Brown round film-coated tablet
Manufacturer packaging unit
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Rosuvastatin Calcium
Prescription medication
Korea Sandos Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.